Jane Street Group, LLC Revance Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022
BUY
$12.36 - $20.31 $741,600 - $1.22 Million
60,000 Added 147.06%
100,800 $1.97 Million
Q4 2021

Feb 15, 2022
BUY
$12.46 - $27.87 $388,752 - $869,544
31,200 Added 325.0%
40,800 $666,000
Q2 2021

Aug 16, 2021
SELL
$26.8 - $31.84 $495,800 - $589,040
-18,500 Reduced 65.84%
9,600 $285,000
Q4 2020

Feb 17, 2021
BUY
$23.41 - $28.34 $657,821 - $796,354
28,100 New
28,100 $796,000

Others Institutions Holding RVNC

# of Institutions
196
Shares Held
81.5M
Call Options Held
490K
Put Options Held
128K
View Full List

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email